We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£515.00
It has never been this cheap. We have no record of a lower price.
£515 today · cheaper than every other day in the last 3 months
Prostate Cancer Nuclear Medicine Diagnostics India Outlook
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 89 days · 89 data points
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 89 days • 1 price levels
Price Analysis
Most common price: £515 (89 days, 100.0%)
Price range: £515 - £515
Price levels: 1 different prices over 89 days
Description
Key Features
Provides a detailed market outlook for prostate cancer nuclear medicine diagnostics in India covering the period from 2023 to 2028.
Includes latent demand estimates in millions of U.S. dollars, also referred to as potential industry earnings (P.I.E.).
Delivers specific data across more than 4,900 cities, states, and union territories throughout India.
Offers comparative benchmarks by reporting the percent share of each city relative to its state and the total Indian market.
Supports the development of effective sales force and distribution strategies through detailed statistical analysis.
Product Specifications
- Format
- paperback
- ASIN
- B0BGKX3YJZ
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 14 September 2022
- Listed Since
- 29 September 2022
Similar Products You Might Like
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan
The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics
Price unavailable
Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028
The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan
The 2025-2030 World Outlook for Prostate Cancer Treatments
Price unavailable
The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention
Price unavailable
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India
Prostate Cancer Therapeutics in Africa 2013-2018 Outlook
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan
The 2023-2028 Outlook for Cancer Testing-Screening in India
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in India
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
The 2023-2028 Outlook for Cancer Screenings in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2025-2030 World Outlook for Nuclear Medicine Equipment
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in the United States
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
The 2023-2028 Outlook for Cancer Supportive Care in the United States
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India
